Sfoglia per RIVISTA
CANCERS
Collezione AOU Città della Salute di Torino

  

Items : 140

Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice. in Cancers / Cancers (Basel). 2024 May 10;16(10):1830. doi: 10.3390/cancers16101830.

2024
AOU Città della Salute di Torino

Botto B; Freilone R; Boccomini C; Morra D; Nicolosi M; Santambrogio E; Fasano F; Legato L; Bisio M; Benevolo Savelli C; Novo M;

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. in Cancers / Cancers (Basel). 2024 Mar 20;16(6):1228. doi: 10.3390/cancers16061228.

2024
AOU Città della Salute di Torino

Merli F; Liberati AM; Pane F; Trentin L; Varettoni M; Tedeschi A; Palumbo G; Scortechini I; Murineddu M; Cuneo A; Ferrara F; Califano C; Selleri C; Perbellini O; Galieni P; Chiarenza A; Tafuri A; Pennese E; Patti C; Coscia M; Cassin R; Massaia M; Laurenti L; Sanna A; Di Renzo N; Frigeri F; Albano F; Sportoletti P; Minoia C; et alii...

Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors. in Cancers / Cancers (Basel). 2024 Jun 28;16(13):2374. doi: 10.3390/cancers16132374.

2024
AOU Città della Salute di Torino

Romagnoli R; Paraluppi G; Rizza G; Colli F; Patrono D; De Stefano N;

What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. in Cancers / Cancers (Basel). 2024 Jan 22;16(2):469. doi: 10.3390/cancers16020469.

2024
AOU Città della Salute di Torino

Tomasso A; Valvano L; Fresa A; Autore F; Innocenti I; Tarasco A; Sabetta R; D'Agostino S; Statuto T; D'Auria F; Mansueto G; Villani O; Pietrantuono G; Vitale C; D'Arena G; Cafaro L; Lamorte D; Laurenti L;

Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. in Cancers / Cancers (Basel). 2024 Feb 21;16(5):865. doi: 10.3390/cancers16050865.

2024
AOU Città della Salute di Torino

Ricardi U; Giaccone L; Bruno B; Cerrano M; Maffini E; Cavallin C; Felicetti F; Bartoncini S; Martin A; Levis M; Dogliotti I;

The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas: A Single Center Experience. in Cancers / Cancers (Basel). 2024 Apr 19;16(8):1574. doi: 10.3390/cancers16081574.

2024
AOU Città della Salute di Torino

Morana G; Rudà R; Morello A; Rizzo F; Salvati LF; Panico F; Pellerino A; Bruno F; Zeppa P; Consoli E; De Marco R; Bianconi A; Cofano F; Melcarne A; Garbossa D;

Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. in Cancers / Cancers (Basel). 2024 Apr 11;16(8):1475. doi: 10.3390/cancers16081475.

2024
AOU Città della Salute di Torino

Tiacci E; Falini B; Pulsoni A; Fianchi L; Morè S; Marchesi F; Stelitano C; Storti S; Annibali O; Volpetti S; Spolzino A; Deodato M; Orsucci L; Kovalchuk S; Trentin L; Cantonetti M; Anastasia A; Maraglino AME; Varettoni M; Tosti ME; Broccoli A; Criscuolo M; Zinzani PL; Pagano L;

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital. in Cancers / Cancers (Basel). 2023 Sep 29;15(19):4800. doi: 10.3390/cancers15194800.

2023
AOU Città della Salute di Torino

Paulino Pereira LJ; Reesink DJ; de Bruin P; Gandaglia G; van der Hoeven EJRJ; Marra G; Prinsen A; Rajwa P; Soeterik T; Kasivisvanathan V; Wever L; Zattoni F; van Melick HHE; van den Bergh RCN;

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. in Cancers / Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623.

2023
AOU Novara
AOU Città della Salute di Torino

Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis. in Cancers / Cancers (Basel). 2023 Oct 17;15(20):5027. doi: 10.3390/cancers15205027.

2023
AOU Città della Salute di Torino

Palandri F; Palumbo GA; Bonifacio M; Elli EM; Tiribelli M; Auteri G; Trawinska MM; Polverelli N; Benevolo G; Tieghi A; Cavalca F; Caocci G; Beggiato E; Binotto G; Cavazzini F; Miglino M; Bosi C; Crugnola M; Bocchia M; Martino B; Pugliese N; Venturi M; Isidori A; Cattaneo D; Krampera M; Pane F; Cilloni D; Semenzato G; Lemoli RM; et alii...

Introduction to the Beckwith-Wiedemann Syndrome and Cancer Special Issue. in Cancers / Cancers (Basel). 2023 Oct 11;15(20):4939. doi: 10.3390/cancers15204939.

2023
AOU Città della Salute di Torino

Kalish JM; Mussa A;

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. in Cancers / Cancers (Basel). 2023 May 30;15(11):2993. doi: 10.3390/cancers15112993.

2023
AOU Città della Salute di Torino

Mauro FR; Giannarelli D; Galluzzo CM; Visentin A; Frustaci AM; Sportoletti P; Vitale C; Reda G; Gentile M; Levato L; Murru R; Armiento D; Molinari MC; Proietti G; Pepe S; De Falco F; Mattiello V; Barabino L; Amici R; Coscia M; Tedeschi A; Girmenia C; Trentin L; Baroncelli S;

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study. in Cancers / Cancers (Basel). 2023 May 15;15(10):2761. doi: 10.3390/cancers15102761.

2023
AOU Città della Salute di Torino

Lo Schirico M; Passera R; Gill J; Dellacasa C; Dogliotti I; Giaccone L; Zompi S; Busca A;

New Strategies for the Treatment of Older Myeloma Patients. in Cancers / Cancers (Basel). 2023 May 10;15(10):2693. doi: 10.3390/cancers15102693.

2023
AOU Città della Salute di Torino

Larocca A; Cani L; Bertuglia G; Bruno B; Bringhen S;

Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial. in Cancers / Cancers (Basel). 2023 Mar 6;15(5):1618. doi: 10.3390/cancers15051618.

2023
AOU Città della Salute di Torino

Casale P; Gontero P; Buffi NM; Kamat AM; De Rosa FG; Lillaz B; Corcione S; Lupia T; Livoti S; Rosazza M; De Bellis M; Mazzoli S; Pizzuto G; Bernasconi V; Lazzeri M; Mancon S; Avolio PP; Contieri R; Hurle R; Soria F;

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. in Cancers / Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512.

2023
AOU Città della Salute di Torino

Boscaro E; Urbino I; Catania FM; Arrigo G; Secreto C; Olivi M; D'Ardia S; Frairia C; Giai V; Freilone R; Ferrero D; Audisio E; Cerrano M;

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center. in Cancers / Cancers (Basel). 2023 Jul 25;15(15):3772. doi: 10.3390/cancers15153772.

2023
AOU Città della Salute di Torino

Roccuzzo G; Giordano S; Granato T; Cavallo F; Mastorino L; Avallone G; Pasini B; Quaglino P; Ribero S;

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study. in Cancers / Cancers (Basel). 2023 Jul 21;15(14):3706. doi: 10.3390/cancers15143706.

2023
AO Cuneo
AOU Città della Salute di Torino

Lemoli RM; Semenzato G; Krampera M; Cuneo A; Pane F; Garibaldi B; Ripamonti A; Mullai R; Mazzoni C; Ceglie S; Polverelli N; Tomassetti S; Martino B; D'Addio A; Mendicino F; Crugnola M; Caocci G; Pugliese N; Heidel FH; Bonifacio M; Tieghi A; Tiribelli M; Binotto G; Cavazzini F; Elli EM; Benevolo G; Paglia S; Breccia M; Auteri G; et alii...

DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review. in Cancers / Cancers (Basel). 2023 Jul 19;15(14):3681. doi: 10.3390/cancers15143681.

2023
AOU Città della Salute di Torino

Ferrari SM; Fallahi P; Antonelli A; Patrizio A; Gambale A; Luongo C; De Martino L; Picariello S; Grandone A; Quaglietta L; De Napoli L; Morganti R; Conzo G; Gennari F; Romano S; Ferrari C; Frascella S; Guglielmo C; Sahli LI; Ghionzoli M; Spinelli C;

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience. in Cancers / Cancers (Basel). 2023 Jul 1;15(13):3457. doi: 10.3390/cancers15133457.

2023
AOU Città della Salute di Torino

Fianchi L; Guolo F; Marchesi F; Cattaneo C; Gottardi M; Restuccia F; Candoni A; Ortu La Barbera E; Fazzi R; Pasciolla C; Finizio O; Fracchiolla N; Delia M; Lessi F; Dargenio M; Bonuomo V; Del Principe MI; Zappasodi P; Picardi M; Basilico C; Piedimonte M; Minetto P; Giordano A; Chiusolo P; Prezioso L; Buquicchio C; Melillo LMA; Zama D; Farina F; et alii...

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. in Cancers / Cancers (Basel). 2023 Jan 5;15(2):355. doi: 10.3390/cancers15020355.

2023
AOU Città della Salute di Torino

Banna GL; Albano D; Dondi F; Bertagna F; Annunziata S; Rizzo A; Racca M; Dall'Armellina S; Treglia G; Rescigno P;

Performance Metrics of the Scoring System for the Diagnosis of the Beckwith-Wiedemann Spectrum (BWSp) and Its Correlation with Cancer Development. in Cancers / Cancers (Basel). 2023 Jan 26;15(3):773. doi: 10.3390/cancers15030773.

2023
AOU Città della Salute di Torino

Mussa A; Ferrero GB; Riccio A; Russo S; Sparago A; Pignata L; Tannorella P; Prada E; Vitale R; Grammegna A; D'Elia G; Bontempo P; Melis D; Macchiaiolo M; Bartuli A; Tarani L; Leoni C; Carli D; Cardaropoli S; Milani D; Cocchi G; Luca M;

Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2. in Cancers / Cancers (Basel). 2023 Jan 19;15(3):630. doi: 10.3390/cancers15030630.

2023
AOU Città della Salute di Torino

Sessa F; Maggi S; Gacci M; On Behalf Of The Pros-It Study Group; Nicoletti R; De Nunzio C; Porreca A; Magrini SM; Mirone V; Tubaro A; Serni S; Gontero P; Noale M;

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. in Cancers / Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Sangiolo D; Turinetto M; Scotto G; Borsotti L; Paolini B; Puppo A; Cormio G; Marinaccio M; Carella C; Mandato VD; Parisi A; Biglia N; Sikokis A; Zanchi L; Mammoliti S; Artioli G; Picardo E; Maldi E; Andreetta C; Raspagliesi F; Pignata S; Ghisoni E; Tuninetti V; Valabrega G; Di Maio M;

Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. in Cancers / Cancers (Basel). 2023 Feb 4;15(4):1002. doi: 10.3390/cancers15041002.

2023
AOU Città della Salute di Torino
ASL Torino 4

Giai V; Busca A; Aydin S; Dellacasa CM; Iovino G; D'Ardia S; Audisio E; Cerrano M; Passera R;

Impact of Stain Normalization on Pathologist Assessment of Prostate Cancer: A Comparative Study. in Cancers / Cancers (Basel). 2023 Feb 27;15(5):1503. doi: 10.3390/cancers15051503.

2023
AOU Città della Salute di Torino

Fraggetta F; Molinari F; Mogetta A; Pennisi O; Michielli N; Scotto M; Balmativola D; Caputo A; Salvi M;

Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period. in Cancers / Cancers (Basel). 2023 Feb 20;15(4):1347. doi: 10.3390/cancers15041347.

2023
AOU Città della Salute di Torino

Pisani F; Caputo F; Ambrosini A; Argiolas D; Simone S; Mangino M; Cantaluppi V; Tisone G; Veroux M; Campise M; Citterio F; Iaria M; Todeschini P; Busnach G; Bossini N; Biancone L; Furian L; Cimaglia C; Serraino D; Piselli P; Taborelli M;

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study. in Cancers / Cancers (Basel). 2023 Feb 2;15(3):955. doi: 10.3390/cancers15030955.

2023
AOU Città della Salute di Torino

Vallelonga F; Milan A; Veglio F; Catarinella C; Leone D; Gay F; Bringhen S; Astarita A; Mingrone G; Airale L; Cesareo M; Colomba A;

Implications of an Underlying Beckwith-Wiedemann Syndrome for Wilms Tumor Treatment Strategies. in Cancers / Cancers (Basel). 2023 Feb 17;15(4):1292. doi: 10.3390/cancers15041292.

2023
AOU Città della Salute di Torino

Fagioli F; Spadea M; Tirtei E; Spreafico F; Carli D; Biasoni D; Gerocarni Nappo S; Morosi C; Zucchetti G; Cotti R; Garelli E; Quarello P;

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience. in Cancers / Cancers (Basel). 2023 Feb 10;15(4):1149. doi: 10.3390/cancers15041149.

2023
AOU Città della Salute di Torino

Milan A; Veglio F; Gay F; Vallelonga F; Paladino A; Leone D; Cesareo M; Airale L; Mingrone G; Astarita A; Bringhen S; Catarinella C; Colomba A;

Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. in Cancers / Cancers (Basel). 2023 Dec 25;16(1):117. doi: 10.3390/cancers16010117.

2023
AOU Città della Salute di Torino
ASL Città di Torino

Turletti A; Tonini G; Tinari N; Spazzapan S; Tagliaferri P; Romagnoli E; Sarobba G; Ricciardi G; Riccardi F; Putzu C; Montemurro F; Michelotti A; Mattioli R; Marchetti P; Livi L; Latini L; Giotta F; Giovanardi F; Gamucci T; Garrone O; Gennari A; Giordano M; Forcignanò R; Ferraù F; Foladore S; Beano A; De Placido S; Del Mastro L; De Laurentiis M; et alii...

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Cancers / Cancers (Basel). 2023 Dec 22;16(1):78. doi: 10.3390/cancers16010078.

2023
AOU Città della Salute di Torino

Nichols G; Tasian SK; Reinhardt D; Kaspers G; Norton A; Tomizawa D; Petit A; Locatelli F; Lukin J; van Tinteren H; Di Laurenzio L; Willemse M; Gueguen G; Goemans BF; Bautista F; Karol SE; Ishimaru S; Ceolin V; Kolb EA; Zwaan CM; Cooper TM;

Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. in Cancers / Cancers (Basel). 2023 Dec 21;16(1):46. doi: 10.3390/cancers16010046.

2023
AOU Città della Salute di Torino

Benevolo Savelli C; Clerico M; Botto B; Secreto C; Cavallo F; Dellacasa C; Busca A; Bruno B; Freilone R; Cerrano M; Novo M;

MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. in Cancers / Cancers (Basel). 2023 Dec 20;16(1):41. doi: 10.3390/cancers16010041.

2023
AOU Città della Salute di Torino

Turinetto M; Ricotti A; Marchetti C; Pisano C; Zamagni C; Cassani C; Malaguti P; Baldoni A; Scollo P; Scandurra G; Parisi A; Artioli G; Palaia I; Vertechy L; Bergamini A; Picardo E; Tuninetti V; Scotto G; Scambia G; Pignata S; Valabrega G;

Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines. in Cancers / Cancers (Basel). 2023 Apr 7;15(8):2199. doi: 10.3390/cancers15082199.

2023
AOU Città della Salute di Torino

Mereu E; Abbo D; Paradzik T; Cumerlato M; Bandini C; Labrador M; Maccagno M; Ronchetti D; Manicardi V; Neri A; Piva R;

Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines in Cancers

2023
AOU Città della Salute di Torino

Mereu E; Abbo D; Paradzik T; Cumerlato M; Bandini C; Labrador M; Maccagno M; Ronchetti D; Manicardi V; Neri A; Piva R;

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study in Cancers

2023
AOU Città della Salute di Torino

Lo Schirico M; Passera R; Gill J; Dellacasa C; Dogliotti I; Giaccone L; Zompi S; Busca A;

New Strategies for the Treatment of Older Myeloma Patients in Cancers

2023
AOU Città della Salute di Torino

Larocca A; Cani L; Bertuglia G; Bruno B; Bringhen S;

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study in Cancers

2023
AOU Città della Salute di Torino

Mauro FR; Giannarelli D; Galluzzo CM; Visentin A; Frustaci AM; Sportoletti P; Vitale C; Reda G; Gentile M; Levato L; Murru R; Armiento D; Molinari MC; Proietti G; Pepe S; De Falco F; Mattiello V; Barabino L; Amici R; Coscia M; Tedeschi A; Girmenia C; Trentin L; Baroncelli S;

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors in Cancers

2023
AOU Città della Salute di Torino

Boscaro E; Urbino I; Catania FM; Arrigo G; Secreto C; Olivi M; D’Ardia S; Frairia C; Giai V; Freilone R; Ferrero D; Audisio E; Cerrano M;

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience in Cancers

2023
AOU Città della Salute di Torino

Fianchi L; Guolo F; Marchesi F; Cattaneo C; Gottardi M; Restuccia F; Candoni A; Ortu La Barbera E; Fazzi R; Pasciolla C; Finizio O; Fracchiolla N; Delia M; Lessi F; Dargenio M; Bonuomo V; Del Principe MI; Zappasodi P; Picardi M; Basilico C; Piedimonte M; Minetto P; Giordano A; Chiusolo P; Prezioso L; Buquicchio C; Melillo LMA; Zama D; Farina F; et alii...

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center in Cancers

2023
AOU Città della Salute di Torino

Roccuzzo G; Giordano S; Granato T; Cavallo F; Mastorino L; Avallone G; Pasini B; Quaglino P; Ribero S;

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study in Cancers

2023
AOU Città della Salute di Torino

Fracchiolla NS; Sciumè M; Papayannidis C; Vitale A; Chiaretti S; Annunziata M; Giglio F; Salutari P; Forghieri F; Lazzarotto D; Lunghi M; Imovilli A; Scappini B; Bonifacio M; Dargenio M; Gurrieri C; Todisco E; Defina M; Del Principe MI; Zappasodi P; Cerrano M; Santoro L; Tagliaferri E; Barozzi E; De Roberto P; Canzi M; Buzzatti E; Sartor C; Passamonti F; et alii...

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis in Cancers

2023
AOU Città della Salute di Torino

Palandri F; Palumbo GA; Bonifacio M; Elli EM; Tiribelli M; Auteri G; Trawinska MM; Polverelli N; Benevolo G; Tieghi A; Cavalca F; Caocci G; Beggiato E; Binotto G; Cavazzini F; Miglino M; Bosi C; Crugnola M; Bocchia M; Martino B; Pugliese N; Venturi M; Isidori A; Cattaneo D; Krampera M; Pane F; Cilloni D; Semenzato G; Lemoli RM; et alii...

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital in Cancers

2023
AOU Città della Salute di Torino

Paulino Pereira LJ; Reesink DJ; de Bruin P; Gandaglia G; van der Hoeven EJRJ; Marra G; Prinsen A; Rajwa P; Soeterik T; Kasivisvanathan V; Wever L; Zattoni F; van Melick HHE; van den Bergh RCN;

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact. in Cancers / Cancers (Basel). 2022 Sep 27;14(19):4699. doi: 10.3390/cancers14194699.

2022
AOU Città della Salute di Torino
AO Ordine Mauriziano

Castellano I; Bertero L; Cassoni P; Tampieri C; Mangherini L; Biglia N; D'Alonzo M; Borella F; Metovic J;

Employment among Childhood Cancer Survivors: A Systematic Review and Meta-Analysis. in Cancers / Cancers (Basel). 2022 Sep 22;14(19):4586. doi: 10.3390/cancers14194586.

2022
AOU Città della Salute di Torino

Pira E; Fagioli F; Brignardello E; Ciocan C; Pinto T; Arvat E; Dionisi-Vici M; Gatti F; Clari M; Conti A; Felicetti F; Godono A;

Urinary Zinc Loss Identifies Prostate Cancer Patients. in Cancers / Cancers (Basel). 2022 Oct 28;14(21):5316. doi: 10.3390/cancers14215316.

2022
AOU Città della Salute di Torino

Occhipinti S; Gontero P; Giovarelli M; Novelli F; Gesmundo I; Mengozzi G; Oderda M; Maddalone MG;

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors. in Cancers / Cancers (Basel). 2022 Oct 18;14(20):5108. doi: 10.3390/cancers14205108.

2022
AOU Città della Salute di Torino

Bruno B; Placantonakis DG; Suryadevara CM; Leone S; Aroldi A; Mina R; Boccalatte F;

Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study. in Cancers / Cancers (Basel). 2022 Nov 9;14(22):5513. doi: 10.3390/cancers14225513.

2022
ASL Torino 4
AOU Città della Salute di Torino

Parisi A; Ghidini M; Ramai D; Garrone O; Germini A; de Angelis N; Memeo R; Facciorusso A; Gjoni E; Roberto M; De Tursi M; Berardi R; Morelli C; Gelsomino F; Giampieri R; Depetris I; Zurlo IV; Nigro O; Filippi R; Salvatore L; Bonomi A; Cotsoglou C; Granieri S;

Sinonasal Side Effects of Chemotherapy and/or Radiation Therapy for Head and Neck Cancer: A Literature Review. in Cancers / Cancers (Basel). 2022 May 7;14(9):2324. doi: 10.3390/cancers14092324.

2022
AOU Città della Salute di Torino

Pecorari G; Ricardi U; Airoldi M; Ostellino O; Cavallin C; Iorio GC; Briguglio M; Pizzo C; Cravero E; Riva G;

FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD). in Cancers / Cancers (Basel). 2022 May 17;14(10):2475. doi: 10.3390/cancers14102475.

2022
AOU Città della Salute di Torino

Conter V; Basso G; Cazzaniga G; Biondi A; Valsecchi MG; Rizzari C; Barisone E; Testi AM; Parasole R; Locatelli F; Villa T; Buldini B; Silvestri D; Andriano N; Lo Nigro L;

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience. in Cancers / Cancers (Basel). 2022 Mar 13;14(6):1471. doi: 10.3390/cancers14061471.

2022
AOU Città della Salute di Torino

Burnelli R; Mascarin M; Haupt R; Mura RM; Garaventa A; Parodi S; Muggeo P; De Santis R; Sau A; Provenzi M; Amoroso L; Casini T; Farruggia P; Facchini E; Buffardi S; Rossi F; Bianchi M; Zecca M; Vinti L; Bernasconi S; Pillon M; Sala A; D'Amico S; Guerrini G;

Molecular Imaging and Theragnostics of Thyroid Cancers. in Cancers / Cancers (Basel). 2022 Mar 1;14(5):1272. doi: 10.3390/cancers14051272.

2022
AOU Città della Salute di Torino

Petranovic Ovcaricek P; Giovanella L; Deandreis D; Vrachimis A; Campenni A;

LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications. in Cancers / Cancers (Basel). 2022 Jun 4;14(11):2788. doi: 10.3390/cancers14112788.

2022
AO Ordine Mauriziano
AOU Città della Salute di Torino

Yu H; Wang Z; Loo L; Benedetto C; Fu Y; Wang J; Katsaros D; Biglia N;

Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement. in Cancers / Cancers (Basel). 2022 Jul 11;14(14):3378. doi: 10.3390/cancers14143378.

2022
AOU Città della Salute di Torino

Caccialanza R; Pedrazzoli P; De Lorenzo F; Lezo A; Barat V; Muratore E; Leardini D; Masetti R; Diamanti A; Mastronuzzi A; Tripodi SI; Zecca M; Trovato CM; Fabozzi F;

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers. in Cancers / Cancers (Basel). 2022 Jan 15;14(2):426. doi: 10.3390/cancers14020426.

2022
AOU Città della Salute di Torino

Menna G; Petruzziello F; Cesaro S; Cellini M; Barisone E; Rizzari C; Putti MC; Colombini A; Testi AM; Bertorello N; Stellato P; De Matteo A; Beneduce G; Parasole R;

Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals. in Cancers / Cancers (Basel). 2022 Feb 6;14(3):828. doi: 10.3390/cancers14030828.

2022
AOU Città della Salute di Torino

Saracco GM; Ciancio A; Nicolosi A; Birolo G; Bombaci F; Rosati G; Santaniello U; Caviglia GP; Troshina G;

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. in Cancers / Cancers (Basel). 2022 Feb 4;14(3):791. doi: 10.3390/cancers14030791.

2022
AOU Città della Salute di Torino

Maerevoet M; Shah J; Canales M; Chamoun K; Corona K; Xu J; Ku M; Samal P; Vassilakopoulos TP; Offner F; Egyed M; Schuster M; Sancho JM; Bakhshi S; Warzocha K; Gurion R; Caimi P; Jaeger U; Hamad N; Kuruvilla J; Cruz F; Cavallo F; Thieblemont C; Hill B; Choquet S; Kalakonda N; Vermaat JSP; Casasnovas RO; Follows G; et alii...

Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort. in Cancers / Cancers (Basel). 2022 Dec 28;15(1):189. doi: 10.3390/cancers15010189.

2022
AOU Città della Salute di Torino

Todeschini P; Biancone L; Gontero P; On Behalf Of The Collaborators; Gandaglia G; Soeterik T; Breda A; Rodriguez-Faba O; Lebacle C; Kasivisvanathan V; Kulkarni M; Olsburgh J; Tilki D; Mesnard B; Hedli O; Branchereau J; Timsit MO; Dariane C; Oderda M; Peretti F; Soria F; Marra G;

Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. in Cancers / Cancers (Basel). 2022 Dec 26;15(1):138. doi: 10.3390/cancers15010138.

2022
AOU Città della Salute di Torino

Novelli F; Srivastava AK; Guadagnin G; Cappello P;

Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. in Cancers / Cancers (Basel). 2022 Dec 25;15(1):125. doi: 10.3390/cancers15010125.

2022
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Weiderpass E; Vineis P; Matullo G; Agudo A; Amiano P; Saieva C; Riboli E; Heath AK; Trobajo-Sanmartín C; Schulze MB; Huerta JM; Tumino R; Agnoli C; Johnson T; Kaaks R; Rodriguez-Barranco M; Smith-Byrne K; Panico S; Sacerdote C; Filiberti RA; Rena O; Mirabelli D; Dianzani I; Grosso F; Sculco M; Magnani C; Mencoboni M; Ferrante D; Allione A; et alii...

A Systematic Review of Amino Acid PET Imaging in Adult-Type High-Grade Glioma Surgery: A Neurosurgeon's Perspective. in Cancers / Cancers (Basel). 2022 Dec 23;15(1):90. doi: 10.3390/cancers15010090.

2022
AOU Città della Salute di Torino

Cofano F; Garbossa D; Melcarne A; Zeppa P; Morana G; Deandreis D; Zotta M; Bianconi A; Pesaresi A; De Marco R;

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? in Cancers / Cancers (Basel). 2022 Aug 21;14(16):4039. doi: 10.3390/cancers14164039.

2022
AOU Città della Salute di Torino

Annunziata S; Racca M; Treglia G; Lanni V; Zagaria L; Perotti G; Pizzuto DA; Dall'Armellina S; Rizzo A;

Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late Effects. in Cancers / Cancers (Basel). 2022 Aug 18;14(16):3984. doi: 10.3390/cancers14163984.

2022
AOU Città della Salute di Torino

Felicetti F; Brignardello E; Fagioli F; Pira E; Varetto A; Biasin E; Zucchetti G; Conti A; Clari M; Fortunati N; Gatti F; Castiglione A; Godono A; Dionisi-Vici M;

Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program in Cancers

2022
AOU Città della Salute di Torino

Pellerino A; Soffietti R; Bruno F; Manna R; Muscolino E; Botta P; Palmiero R; Rudà R;

Perineural invasion in vulvar squamous-cell carcinoma is an independent risk factor for cancer-specific survival, but not for locoregional recurrence: results from a single tertiary referral center in Cancers

2022
AOU Città della Salute di Torino

Micheletti L; Borella F; Preti M; Frau V; Cosma S; Privitera S; Bertero L; Benedetto C;

The impact of vulvar cancer on psychosocial and sexual functioning: A literature review in Cancers

2022
AOU Città della Salute di Torino

Malandrone F; Bevilacqua F; Merola M; Gallio N; Ostacoli L; Carletto S; Benedetto C;

FLT3?ITD in Children with Early T?cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) in Cancers

2022
AOU Città della Salute di Torino

Lo Nigro L; Andriano N; Buldini B; Silvestri D; Villa T; Locatelli F; Parasole R; Barisone E; Testi AM; Biondi A; Valsecchi MG; Rizzari C; Conter V; Basso G; Cazzaniga G;

Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? in Cancers

2022
AOU Città della Salute di Torino

Pellerino A; Bruno F; Palmiero R; Pronello E; Bertero L; Soffietti R; Rudà R;

Molecular Imaging and Theragnostics of Thyroid Cancers in Cancers

2022
AOU Città della Salute di Torino

Ovcaricek PP; Vrachims A; Campenni A; Deandreis D; Giovanella L;

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers in Cancers

2022
AOU Città della Salute di Torino

Barisone E; Parasole R; Menna G; Cellini M; Cesaro S; Rizzari C; Putti MC; Colombini A; Bertorello N; Testi AM; Stellato P; De Matteo A; Beneduce G; Petruzziello F;

Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors. in Cancers / Cancers (Basel). 2021 Oct 18;13(20):5214. doi: 10.3390/cancers13205214.

2021
AOU Città della Salute di Torino

Frassoni F; Podestà M; Cilloni D; Fagioli F; Zecca M; Haupt R; Biasin E; Muraca M; Bartolucci M; Petretto A; Dagnino M; Sabatini F; Marimpietri D; Morandi F; Bruno S; Vigliarolo T; Ravera S;

Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021. in Cancers / Cancers (Basel). 2021 Oct 11;13(20):5075. doi: 10.3390/cancers13205075.

2021
AOU Città della Salute di Torino

Cerrano M; Audisio E; Busca A; Ferrero D; Giaccone L; Dellacasa C; Aydin S; Freilone R; D'Ardia S; Frairia C; Giai V; Apolito V; Olivi M; Secreto C; Urbino I;

The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study. in Cancers / Cancers (Basel). 2021 Nov 21;13(22):5836. doi: 10.3390/cancers13225836.

2021
AOU Città della Salute di Torino
AO Ordine Mauriziano

Villasco A; Actis S; Bounous VE; Borella F; D'Alonzo M; Ponzone R; De Sanctis C; Benedetto C; Biglia N;

How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO). in Cancers / Cancers (Basel). 2021 May 30;13(11):2702. doi: 10.3390/cancers13112702.

2021
AOU Città della Salute di Torino

Magrini SM; Lohr F; Ricardi U; Spiazzi L; Arcangeli S; Guerini AE; Magli A; Francolini G; Detti B; D'Angelillo RM; Ingrosso G; Bruni A; Nanni S; Borghesi S; Greco D; Gottardo S; Antognoni P; Bartoncini S; Guarneri A; Frassinelli L; Triggiani L; Mazzeo E;

New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment. in Cancers / Cancers (Basel). 2021 May 27;13(11):2636. doi: 10.3390/cancers13112636.

2021
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Matullo G; Magnani C; Mirabelli D; Pirazzini C; Dianzani I; Libener R; Sculco M; La Vecchia M; Ferrante D; Grosso F; Guarrera S; Casalone E; Catalano C; Russo A; Allione A; Cugliari G;

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 24;13(11):2564. doi: 10.3390/cancers13112564.

2021
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Napoli F; Listì A; Zambelli V; Witel G; Bironzo P; Papotti M; Volante M; Scagliotti G; Righi L;

Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study. in Cancers / Cancers (Basel). 2021 May 21;13(11):2519. doi: 10.3390/cancers13112519.

2021
AOU Città della Salute di Torino

Lebbé C; Delyon J; Battistella M; Pages C; Le Goff J; Roux J; Baroudjian B; Cochereau D; La Selva R; Lambert J; Benajiba L;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.

2021
AO Alessandria
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Novello S; Aviles P; Libener R; Leo F; Sandri A; Guerrera F; Comunanza V; Bussolino F; Gigliotti C; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Taulli R; Scagliotti GV; Riganti C;

Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. in Cancers / Cancers (Basel). 2021 May 11;13(10):2305. doi: 10.3390/cancers13102305.

2021
AOU Città della Salute di Torino

Bugianesi E; Saracco GM; Carucci P; Ribaldone DG; Guariglia M; Nicolosi A; Olivero A; Abate ML; Rolle E; Aneli S; Gaia S; Rosso C; Armandi A; Caviglia GP;

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group. in Cancers / Cancers (Basel). 2021 Mar 2;13(5):1053. doi: 10.3390/cancers13051053.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Palmerini E; Picci P; Ferrari S; Ibrahim T; Carretta E; Setola E; Righi A; Marchesi E; Quattrini I; Ferrari V; Ciuffreda L; Zanelli F; Pantaleo MA; Milesi L; Grosso F; Pas T; Vincenzi B; Comandone A; Pizzolorusso A; Brunello A; Gelsomino F; Ferraresi V; Badalamenti G; Romanini A; Buonadonna A; Grignani G; Sanfilippo R;

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. in Cancers / Cancers (Basel). 2021 Mar 15;13(6):1311. doi: 10.3390/cancers13061311.

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Alessandria

Saglio G; Circosta P; Russo S; Aime S; Iurlo A; Stagno F; Pregno P; Bonifacio M; Martino B; Binotto G; Specchia G; Bocchia M; Annunziata M; Luciano L; Pungolino E; Galimberti S; Cignetti A; Nikougoftar Zarif M; Fava C; Spinelli M; Stefania R; Gaidano V; Garello F; Houshmand M;

The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma. in Cancers / Cancers (Basel). 2021 Mar 11;13(6):1235. doi: 10.3390/cancers13061235.

2021
AOU Città della Salute di Torino

Piva R; Neri A; Amodio N; Taiana E; Labrador M; Mereu E; Bandini C; Paradzik T;

Targeting HIF-1? Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL. in Cancers / Cancers (Basel). 2021 Jun 9;13(12):2883. doi: 10.3390/cancers13122883.

2021
AOU Città della Salute di Torino

Godio L; Voena C; Perutelli F; Boccadoro M; Boccellato E; Salvetti C; Jones R; Kopecka J; Todaro M; Riganti C; Griggio V; Vitale C; Coscia M;

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. in Cancers / Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Trentin L; Gentile G; Girmenia C; Martelli M; Gaidano G; Foà R; Cuneo A; Tedeschi A; Molica S; Coscia M; Noto A; Guarente V; Stelitano C; Del Poeta G; Giordano A; Rigolin GM; De Paoli L; Murru R; Gentile M; Levato L; Ielo C; Laurenti L; Ciolli S; Vitale C; Frustaci AM; Chiarenza A; Sportoletti P; Reda G; Visentin A; et alii...

Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. in Cancers / Cancers (Basel). 2021 Jun 18;13(12):3046. doi: 10.3390/cancers13123046.

2021
AOU Città della Salute di Torino

Luksch R; Fagioli F; Longhi A; Prete A; Picci P; Tirtei E; Campello A; Rabusin M; De Leonardis F; Bertulli R; Manzitti C; Grignani G; Coccoli L; Palmerini E; Tamburini A; Podda M; Morosi C; Petraz M; Paioli A; Puma N; Asaftei SD;

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios. in Cancers / Cancers (Basel). 2021 Jul 4;13(13):3360. doi: 10.3390/cancers13133360.

2021
AOU Città della Salute di Torino

van Ravesteyn NT; de Koning HJ; Jarm K; Senore C; Heinävaara S; Heijnsdijk EAM; Geuzinge A; Zielonke N; On Behalf Of The Eu-Topia Consortium;

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2021 Jul 30;13(15):3856. doi: 10.3390/cancers13153856.

2021
AOU Città della Salute di Torino

Coscia M; Griggio V; Perutelli F; Jones R; Comba L; Boccellato E; Vitale C;

Low Levels of Urinary PSA Better Identify Prostate Cancer Patients. in Cancers / Cancers (Basel). 2021 Jul 16;13(14):3570. doi: 10.3390/cancers13143570.

2021
AOU Città della Salute di Torino

Gontero P; Giovarelli M; Novelli F; Molinaro L; Zitella A; Oderda M; Mengozzi G; Occhipinti S;

PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression. in Cancers / Cancers (Basel). 2021 Jan 6;13(2):164. doi: 10.3390/cancers13020164.

2021
AOU Città della Salute di Torino

Giuliani N; Malavasi F; Storti P; Marchica V; Costa F;

Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy. in Cancers / Cancers (Basel). 2021 Jan 30;13(3):532. doi: 10.3390/cancers13030532.

2021
AOU Città della Salute di Torino

Tondini C; Radice P; Peterlongo P; Livraghi L; Franchi M; Zambelli A; Zanardi F; Birolo G; Aneli S; Matullo G; Pizzamiglio S; Verderio P; Volorio S; De Vecchi G; Pensotti V; Zuradelli M; Ogliara P; Vignolo Lutati F; Pasini B; Bondavalli D; Calvello M; Bonanni B; Beltrami B; Azzollini J; Peissel B; Manoukian S; Catucci I; De Nicolo A; Figlioli G; et alii...

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy. in Cancers / Cancers (Basel). 2021 Jan 14;13(2):291. doi: 10.3390/cancers13020291.

2021
AOU Città della Salute di Torino

Ladetto M; Zilioli VR; Re A; Luminari S; Musuraca G; Galimberti S; Ferrero S; Fabbri A; Chiappella A; Barbui AM; Visco C; Marangon M;

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. in Cancers / Cancers (Basel). 2021 Feb 20;13(4):894. doi: 10.3390/cancers13040894.

2021
AOU Città della Salute di Torino

Quaglino E; Cavallo F; Calogero RA; Mengozzi G; Annaratone L; Marchiò C; Peppino G; Conti L; Riccardo F; Arigoni M; Barutello G; Ruiu R;

How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature. in Cancers / Cancers (Basel). 2021 Feb 17;13(4):836. doi: 10.3390/cancers13040836.

2021
AOU Città della Salute di Torino
AOU Novara

Mandato VD; Singh N; Wong RW; Goia M; Disanto MG; Boldorini R; Asaturova A; Carpenito L; Sanguedolce F; Veggiani C; Ragazzi M; Dalla Dea G; de Biase D; Santandrea G; Zizzo M; De Leo A; Ardighieri L; Bernardelli G; Ricci S; De Giorgi F; Bonacini M; Mastrofilippo V; Sileo FG; Aguzzoli L; D'Ippolito G; Falbo AI; Gugnoni M; Torricelli F; Manzotti G; et alii...

Lateralized and Segmental Overgrowth in Children. in Cancers / Cancers (Basel). 2021 Dec 7;13(24):6166. doi: 10.3390/cancers13246166.

2021
AOU Città della Salute di Torino

Resta N; Ferrero GB; Carli D; Cardaropoli S; Mussa A;

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Ordine Mauriziano
AO Alessandria
AOU Novara

Cuneo A; Foà R; Fazi P; Neri A; Guarini A; Rigolin GM; Piciocchi A; Nanni M; Raponi S; Ruocco V; Murru R; Della Starza I; De Propris MS; Del Giudice I; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Gentile M; Tani M; Musuraca G; Gottardi D; Zinzani PL; Molinari A; Gozzetti A; Re F; Orsucci L; Liberati AM; Ilariucci F; et alii...

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.

2021
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Ladetto M; Cortelazzo S; Dreyling M; Kluin-Nelemans HC; Hermine O; Vitolo U; Fabbri A; Latte G; Guarini A; Patti C; Pascarella A; Vallisa D; Spina M; Merli F; Di Renzo N; Cabras MG; Volpetti S; Tani M; Moia R; Del Giudice I; Barbero D; Genuardi E; Ghislieri M; Drandi D; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; et alii...

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2021 Aug 23;13(16):4239. doi: 10.3390/cancers13164239.

2021
AOU Città della Salute di Torino

Laurenti L; Efremov DG; Sgambato A; Mannucci C; Calapai F; De Feo V; Viglioglia V; D'Agostino S; Villani O; Mansueto G; Jones R; Griggio V; D'Arena G; Tomasso A; Valvano L; Statuto T; D'Auria F; Perutelli F; Pietrantuono G; Lamorte D; Coscia M; Vitale C;

Genomic Instability in Multiple Myeloma: A "Non-Coding RNA" Perspective. in Cancers / Cancers (Basel). 2021 Apr 28;13(9):2127. doi: 10.3390/cancers13092127.

2021
AOU Città della Salute di Torino

Amodio N; Neri A; Piva R; Viglietto G; Bandini C; Favasuli VK; Gallo Cantafio ME; Taiana E;

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. in Cancers / Cancers (Basel). 2021 Apr 1;13(7):1631. doi: 10.3390/cancers13071631.

2021
AOU Città della Salute di Torino

Veglio F; Milan A; Rabbia F; Bringhen S; Gay F; Salvini M; Cetani G; Giordana C; Leone D; Bruno G; Cesareo M; Catarinella C; Covella M; Vallelonga F; Airale L; Mingrone G; Astarita A;

Prognostic factors and current treatment strategies for renal cell carcinoma metastatic to the brain: An overview in Cancers

2021
AOU Città della Salute di Torino

Internò V; De Santis P; Stucci LS; Rudà R; Tucci M; Soffietti R; Porta C;

Depatuxizumab mafodotin (Depatux-m) plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of italian association of neuro-oncology (aino) in Cancers

2021
AOU Città della Salute di Torino

Padovan M; Eoli M; Pellerino A; Rizzato S; Caserta C; Simonelli M; Michiara M; Caccese M; Anghileri E; Cerretti G; Rudà R; Zagonel V; Lombardi G;

Leptomeningeal metastases from solid tumors: Recent advances in diagnosis and molecular approaches in Cancers

2021
AOU Città della Salute di Torino

Pellerino A; Brastianos PK; Rudà R; Soffietti R;

Genomic instability in multiple myeloma: A “non?coding rna” perspective in Cancers

2021
AOU Città della Salute di Torino

Taiana E; Cantafio MEG; Favasuli VK; Bandini C; Viglietto G; Piva R; Neri A; Amodio N;

Superficially invasive vulvar squamous cell carcinoma: A 37-year-long experience of a tertiary referral center in Cancers

2021
AOU Città della Salute di Torino

Preti M; Borella F; Gallio N; Bertero L; Heller DS; Vieira-Baptista P; Cosma S; Bevilacqua F; Privitera S; Micheletti L; Benedetto C;

Targeting hif-1? regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll in Cancers

2021
AOU Città della Salute di Torino

Vitale C; Griggio V; Riganti C; Todaro M; Kopecka J; Jones R; Salvetti C; Boccellato E; Perutelli F; Voena C; Godio L; Boccadoro M; Coscia M;

Psychotherapy with music intervention improves anxiety, depression and the redox status in breast cancer patients undergoing radiotherapy: A randomized controlled clinical trial in Cancers

2021
AOU Città della Salute di Torino

Rolla R; Grossini E; Gramaglia C; Zeppegno P; Krengli M; Ferrante D; Bagnati M; Burgio V; Farruggio S;

Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia in Cancers

2021
AOU Città della Salute di Torino

Sgambato A; Mannucci C; Laurenti L; Efremov DG; Calapai F; Viglioglia V; De Feo V; D’agostino S; Villani O; D’arena G; Vitale C; Coscia M; Lamorte D; Pietrantuono G; Perutelli F; D’auria F; Statuto T; Valvano L; Tomasso A; Griggio V; Jones R; Mansueto G;

Low levels of urinary psa better identify prostate cancer patients in Cancers

2021
AOU Città della Salute di Torino

Giovarelli M; Gontero P; Novelli F; Molinaro L; Zitella A; Oderda M; Mengozzi G; Occhipinti S;

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. in Cancers / Cancers (Basel). 2020 Sep 28;12(10):2776. doi: 10.3390/cancers12102776.

2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Olivero A; Carucci P; Rolle E; Rosso C; Abate ML; Risso A; Ribaldone DG; Tandoi F; Saracco GM; Bugianesi E; Gaia S;

Robotic-Assisted Colonoscopy Platform with a Magnetically-Actuated Soft-Tethered Capsule. in Cancers / Cancers (Basel). 2020 Sep 2;12(9):2485. doi: 10.3390/cancers12092485.

2020
AOU Città della Salute di Torino

Verra M; Firrincieli A; Chiurazzi M; Mariani A; Lo Secco G; Forcignanò E; Koulaouzidis A; Menciassi A; Dario P; Ciuti G; Arezzo A;

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. in Cancers / Cancers (Basel). 2020 Oct 31;12(11):3218. doi: 10.3390/cancers12113218.

2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Abate ML; Carucci P; Rolle E; Rosso C; Olivero A; Troshina G; Risso A; Nicolosi A; Ribaldone DG; Armandi A; Tandoi F; Saracco GM; Bugianesi E; Ciancio A; Gaia S;

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy. in Cancers / Cancers (Basel). 2020 Oct 26;12(11):3131. doi: 10.3390/cancers12113131.

2020
AOU Città della Salute di Torino

Teterycz P; Czarnecka AM; Indini A; Labianca A; Rogala P; Cybulska-Stopa B; Quaglino P; Ricardi U; Badellino S; Falkowski S; Mandala M; Rutkowski P;

Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients. in Cancers / Cancers (Basel). 2020 Oct 24;12(11):3106. doi: 10.3390/cancers12113106.

2020
AOU Città della Salute di Torino

Bonello F; Boccadoro M; Larocca A;

Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial. in Cancers / Cancers (Basel). 2020 Nov 9;12(11):3306. doi: 10.3390/cancers12113306.

2020
AOU Città della Salute di Torino

Arcadipane F; Silvetti P; Olivero F; Gastino A; De Luca V; Mistrangelo M; Cassoni P; Racca P; Gallio E; Lesca A; Fiandra C; Ricardi U; Franco P;

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2020 Nov 21;12(11):3470. doi: 10.3390/cancers12113470.

2020
AOU Città della Salute di Torino
AOU Novara

Mirabelli D; Libener R; Pirazzini C; Sculco M; Aspesi A; Viberti C; Ferrante D; Grosso F; Russo A; Casalone E; Allione A; Guarrera S; Catalano C; Cugliari G; Magnani C; Dianzani I; Matullo G;

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival. in Cancers / Cancers (Basel). 2020 May 5;12(5):1163. doi: 10.3390/cancers12051163.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Veltri A; Novello S; Arena V; Racca M; Scapoli P; Liberini V; Passera R; Gallio E; Rampado O; Reale ML; Bertaglia V; Ceci F; Polverari G; Deandreis D;

Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. in Cancers / Cancers (Basel). 2020 Mar 21;12(3):746. doi: 10.3390/cancers12030746.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Hanash SM; Evangelista A; Satolli MA; Spadi R; Giordano D; Momin AA; Capello M; Hong W; Katayama H; Ferrero G; Follia L; Mandili G; Cordero F; Novelli F;

Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades. in Cancers / Cancers (Basel). 2020 Jun 9;12(6):1507. doi: 10.3390/cancers12061507.

2020
AOU Città della Salute di Torino

Matullo G; Pardini B; Vineis P; Sacerdote C; Gontero P; Allasia M; Oderda M; Allione A; Aneli S; Dragomir MP; Naccarati A; Birolo G; Sabo AA;

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. in Cancers / Cancers (Basel). 2020 Jun 8;12(6):1492. doi: 10.3390/cancers12061492.

2020
AOU Città della Salute di Torino

Lamolinara A; Parra K; Valenzuela P; Francia G; Iezzi M; Pericle F; Cavallo F; Rolih V; Caldeira J; Bolli E; Salameh A; Conti L; Barutello G; Riccardo F; Magri J;

Comparison of Hodgkin's Lymphoma in Children and Adolescents. A Twenty Year Experience with MH'96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols. in Cancers / Cancers (Basel). 2020 Jun 18;12(6):1620. doi: 10.3390/cancers12061620.

2020
ASL Cuneo 2
AOU Città della Salute di Torino

Mascarin M; Civino A; Pericoli R; Galimberti D; Sperlì D; Cellini M; Bertolini P; Perruccio K; Cesaro S; Sau A; Mura R; Verzegnassi F; D'Alba I; Porta F; Casini T; De Santis R; Bernasconi S; D'Amico S; Facchini E; Muggeo P; Provenzi M; Farruggia P; Rossi F; Sabattini E; Buffardi S; Bianchi M; Vinti L; Zecca M; Garaventa A; et alii...

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe. in Cancers / Cancers (Basel). 2020 Jul 8;12(7):1841. doi: 10.3390/cancers12071841.

2020
AOU Città della Salute di Torino

Pinato DJ; Lee AJX; Biello F; Seguí E; Aguilar-Company J; Carbó A; Bruna R; Bower M; Rizzo G; Benafif S; Carmona C; Chopra N; Cruz CA; D'Avanzo F; Evans JS; Galazi M; Garcia-Fructuoso I; Dalla Pria A; Newsom-Davis T; Ottaviani D; Patriarca A; Reyes R; Sharkey R; Sng CCT; Wong YNS; Ferrante D; Scotti L; Avanzi GC; Bellan M; et alii...

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. in Cancers / Cancers (Basel). 2020 Jul 3;12(7):1773. doi: 10.3390/cancers12071773.

2020
AOU Città della Salute di Torino
AOU Novara

Caronna R; Corsi A; Ligia S; Di Prima A; Maestrini G; Buscicchio G; Rago A; De Paoli L; Coscia M; Vitale C; Riminucci M; Nicolai E; Porrazzo M; Gaidano G; Mauro FR;

CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults. in Cancers / Cancers (Basel). 2020 Jan 28;12(2):303. doi: 10.3390/cancers12020303.

2020
AOU Città della Salute di Torino

Malavasi F; Faini AC; Massari E; Rondoni M; Maffini E; Lanza F;

Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. in Cancers / Cancers (Basel). 2020 Jan 23;12(2):282. doi: 10.3390/cancers12020282.

2020
AOU Città della Salute di Torino

Vitale C; Montalbano MC; Salvetti C; Boccellato E; Griggio V; Boccadoro M; Coscia M;

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. in Cancers / Cancers (Basel). 2020 Aug 4;12(8):2156. doi: 10.3390/cancers12082156.

2020
AOU Città della Salute di Torino

Cassoni P; Benedetto C; Scotto G; Valabrega G; Preti M; Gemmiti S; Katsaros D; Carosso A; Cosma S; Bovetti M; Gambella A; Morrone A; Bertero L; Borella F;

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.

2020
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria

Spinelli O; Rambaldi A; Bassan R; Fracchiolla N; Corradini P; Campiotti L; Todisco E; Scattolin A; Ciceri F; Tajana M; Mattei D; Cavattoni I; Borlenghi E; De Paoli L; Audisio E; Terruzzi E; Gianfaldoni G; Oldani E; Lussana F; Intermesoli T; Caprioli C; Stefanoni P; Buklijas K; Elidi L; Michelato A; Salmoiraghi S; Pavoni C; Zanghì P; Cavagna R; et alii...

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. in Cancers / Cancers (Basel). 2019 Sep 25;11(10):1431. doi: 10.3390/cancers11101431.

2019
AOU Città della Salute di Torino
ASL Alessandria

Frassoldati A; Romano G; Ciuffreda L; Fasola G; Battiloro C; Giannetta L; Buosi R; Tiseo M; Foltran L; Chiari R; Finocchiaro G; Bidoli P; Morabito A; Piccirillo MC; Sacco A; Pasquale R; Esposito Abate R; Cappuzzo F; Normanno N; de Marinis F;

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. in Cancers / Cancers (Basel). 2019 Nov 5;11(11):1735. doi: 10.3390/cancers11111735.

2019
AOU Città della Salute di Torino

Bonello F; Pulini S; Ballanti S; Gentile M; Spada S; Annibali O; Omedé P; Ronconi S; Cangialosi C; Podda L; Palmas A; Malfitano A; Rivoli G; Belotti A; Ciambelli F; Vincelli ID; Cafro AM; Innao V; Palumbo A; Sonneveld P; Spencer A; Hájek R; Boccadoro M; Gay F;

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy. in Cancers / Cancers (Basel). 2019 May 3;11(5):622. doi: 10.3390/cancers11050622.

2019
AOU Città della Salute di Torino

Bruno G; Bringhen S; Maffei I; Iannaccone A; Crea T; Ravera A; Astarita A; Vallelonga F; Salvini M; Gay F; Veglio F; Milan A;

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk. in Cancers / Cancers (Basel). 2019 Mar 30;11(4):452. doi: 10.3390/cancers11040452.

2019
AOU Città della Salute di Torino

Osella-Abate S; Bertero L; Senetta R; Mariani S; Lisa F; Coppola V; Metovic J; Pasini B; Puig S S; Fierro MT; Manrique-Silva E; Kumar R; Nagore E; Cassoni P; Ribero S;

Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience. in Cancers / Cancers (Basel). 2019 Mar 15;11(3):369. doi: 10.3390/cancers11030369.

2019
AOU Città della Salute di Torino

Aglietta M; Vaira M; Ferraris R; Cagnazzo C; Marino D; Lombardi P; Chilà G; Depetris I; Filippi R; Calella MG; Colombi F; Fenocchio E; Leone F;

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12. in Cancers / Cancers (Basel). 2019 Jun 26;11(7):896. doi: 10.3390/cancers11070896.

2019
AOU Città della Salute di Torino
AO Cuneo

Laurenti L; Ferrajoli A; Foà R; Sica S; Visentin A; Reda G; Tisi MC; Vitale C; Rigolin GM; Ferretti A; Efremov DG; Vincelli D; Murru R; D'Arena G; Falcucci P; Molica S; Morabito F; Gentile M; Frustaci AM; Mauro FR; Gozzetti A; Cuneo A; Visco C; Coscia M; Cortelezzi A; Trentin L; Corrente F; Innocenti I; Strati P; et alii...

Longitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith?Wiedemann Syndrome. in Cancers / Cancers (Basel). 2019 Jan 14;11(1):86. doi: 10.3390/cancers11010086.

2019
AOU Città della Salute di Torino

Ferrero GB; Pavanello E; Kalish JM; Fagioli F; Sauro P; Pagliardini V; Pagliardini S; Carli D; Mussa A; Ciuffreda VP;

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma. in Cancers / Cancers (Basel). 2019 Dec 19;12(1):15. doi: 10.3390/cancers12010015.

2019
AOU Città della Salute di Torino

Bonello F; Mina R; Boccadoro M; Gay F;

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. in Cancers / Cancers (Basel). 2019 Dec 13;11(12):2015. doi: 10.3390/cancers11122015.

2019
AOU Città della Salute di Torino

D'Agostino M; Bertamini L; Oliva S; Boccadoro M; Gay F;

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. in Cancers / Cancers (Basel). 2018 Jun 1;10(6):175. doi: 10.3390/cancers10060175.

2018
AO Cuneo
AOU Città della Salute di Torino
ASL Alessandria

Aielli F; Valle A; Tonini G; Scelzi E; Sofia M; Ricci S; Papa A; De Santis S; Orsetti R; Moroso S; Pascoletti G; Menardo V; Miotti D; Mazzei T; Melotti RM; Mattioli R; Masedu F; Mameli S; Iaffaioli V; Liguori S; Palermo L; Guardamagna V; Fusco F; Costanzo BVP; Degiovanni D; Chiurazzi B; Cartenì G; Blasi L; Bandera M; et alii...

Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases. in Cancers / Cancers (Basel). 2018 Feb 20;10(2):56. doi: 10.3390/cancers10020056.

2018
AOU Città della Salute di Torino

Roato I; Ferracini R;

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. in Cancers / Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051.

2018
AOU Città della Salute di Torino

Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F;